Skip to main content

Free Content Smoking-related diseases: the importance of COPD

Download Article:
(PDF 113.744140625 kb)
SETTING: Smoking plays a major role in a variety of diseases. Despite a strong relationship between smoking and chronic obstructive pulmonary disease (COPD), cardiovascular disease and lung cancer attract greater attention.

OBJECTIVE: To assess the burden of illness produced by smoking.

DESIGN: Smoking-attributable risk (SAR) and smoking-attributable disease burden (mortality, morbidity, and cost) were estimated for four conditions: COPD, coronary heart disease (CHD), lung cancer, and stroke.

RESULTS: Smoking-attributable deaths worldwide were: 1772580 COPD, 1 277000 CHD, 822150 lung cancer, and 788580 stroke. Smoking-attributable disability adjusted life years (DALYs) were: 47232000 COPD, 18106000 CHD, and 11052000 stroke. US smoking-attributable costs were: $26.0 billion CHD, $24.9 billion COPD, and $9.0 billion stroke. US smoking-attributable annual hospitalizations were: 520000 COPD, 460000 CHD, and 183000 stroke.

CONCLUSIONS: Cardiovascular disease and lung cancer rank high in absolute estimates of disease burden. However, COPD has a more substantial smoking-attributable disease burden. COPD deserves more attention in the health care sector. Smoking cessation programs, pharmacological interruption of the pathophysiology of smoking-related COPD, and effective management of COPD should be key targets of intervention and research.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: COPD; attributable risk; chronic obstructive; disease burden; pulmonary disease; smoking

Document Type: Regular Paper

Affiliations: 1: Cerner Health Insights, Beverly Hills, California, USA 2: Boehringer Ingelheim GmbH, Ingelheim, Germany

Publication date: 2004-12-01

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more